Free Trial

Tempus AI (NASDAQ:TEM) Stock Price Down 1.4% - Time to Sell?

Tempus AI logo with Medical background

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) shares were down 1.4% during mid-day trading on Thursday . The company traded as low as $66.62 and last traded at $69.10. Approximately 10,672,401 shares were traded during mid-day trading, an increase of 51% from the average daily volume of 7,059,910 shares. The stock had previously closed at $70.11.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Wolfe Research downgraded shares of Tempus AI from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Piper Sandler upped their price target on Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a research note on Thursday, May 15th. William Blair reaffirmed a "market perform" rating on shares of Tempus AI in a research note on Tuesday, February 25th. BTIG Research assumed coverage on Tempus AI in a research note on Monday, April 21st. They set a "buy" rating and a $60.00 target price on the stock. Finally, Guggenheim restated a "buy" rating on shares of Tempus AI in a report on Tuesday, February 25th. Six investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, Tempus AI currently has an average rating of "Moderate Buy" and an average target price of $63.42.

Read Our Latest Research Report on TEM

Tempus AI Price Performance

The company has a current ratio of 1.71, a quick ratio of 1.56 and a debt-to-equity ratio of 2.45. The firm has a market capitalization of $11.96 billion and a PE ratio of -8.86. The company has a fifty day moving average price of $57.63 and a two-hundred day moving average price of $52.62.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.03. The business had revenue of $255.74 million during the quarter, compared to the consensus estimate of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The firm's revenue was up 75.4% compared to the same quarter last year. Sell-side analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Insider Buying and Selling

In other Tempus AI news, EVP Erik Phelps sold 8,415 shares of the company's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $63.21, for a total transaction of $531,912.15. Following the completion of the transaction, the executive vice president now owns 149,096 shares in the company, valued at approximately $9,424,358.16. This represents a 5.34% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Andrew Polovin sold 17,552 shares of Tempus AI stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $63.43, for a total transaction of $1,113,323.36. Following the completion of the sale, the executive vice president now directly owns 138,877 shares in the company, valued at approximately $8,808,968.11. The trade was a 11.22% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 308,580 shares of company stock worth $20,156,721 in the last 90 days. Company insiders own 27.60% of the company's stock.

Institutional Trading of Tempus AI

A number of institutional investors have recently modified their holdings of TEM. ARK Investment Management LLC lifted its holdings in Tempus AI by 35.9% in the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company's stock valued at $361,867,000 after acquiring an additional 1,981,755 shares during the period. Vanguard Group Inc. grew its position in Tempus AI by 6,247.5% during the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company's stock worth $289,204,000 after buying an additional 5,900,668 shares during the period. Nikko Asset Management Americas Inc. lifted its position in shares of Tempus AI by 31.5% during the 1st quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company's stock valued at $205,401,000 after acquiring an additional 1,021,460 shares during the period. Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Tempus AI by 31.4% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock worth $205,284,000 after acquiring an additional 1,016,384 shares during the period. Finally, Franklin Resources Inc. boosted its position in shares of Tempus AI by 240.5% in the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock worth $93,251,000 after buying an additional 1,950,862 shares in the last quarter. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

About Tempus AI

(Get Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Tempus AI Right Now?

Before you consider Tempus AI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.

While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines